FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...In addition, careful control of the impurities and degradation products in the drug substance and drug formulation.....MDI products are unique with respect to formulation, container, closure, manufacturing, in-process.....Even slight changes in the formulation, drug substance particle size, valve, or actuator can have a..
http://www.fda.gov/cder/fdama/difconc.htm (score=100)
...14927 15-Jun-00 EAGLE STAINLESS CONTAINER "EAGLE STAINLESS CONTAINER AS MFG IN WARMINSTER.....6441 26-Jun-86 ALGROUP WHEATON RUBBER CLOSURE FORMULATION B5000-45 GRAY MFG IN SALISBURY.....14821 07-Apr-00 SKC INC SKYROL PET FILMS FOR PACKAGING DRUG PRODUCTS AS MFG IN COVINGTON..
http://www.fda.gov/cder/dmf/text/3Q2004Type3ACTIVETEXT.txt (score=87)
...14927 III 15-Jun-00 EAGLE STAINLESS CONTAINER "EAGLE STAINLESS CONTAINER AS MFG IN.....6441 III 26-Jun-86 ALGROUP WHEATON RUBBER CLOSURE FORMULATION B5000-45 GRAY MFG IN.....14821 III 07-Apr-00 SKC INC SKYROL PET FILMS FOR PACKAGING DRUG PRODUCTS AS MFG IN..
http://www.fda.gov/cder/dmf/text/4Q2004TYPEIIIACTIVETEXT.txt (score=87)
MDI and DPI Drug Products
...Documentation in Drug Applications for Container and Closure Systems Used for the.....an internal reservoir containing sufficient formulation for multiple doses that are.....container and closure system as a result of direct contact with the formulation of the MDI..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=46)
þÿ
...formulation components or leaching from the container closure system, chemical impurities.....drug products can and has occurred as a result of entry through LDPE container closure.....adequate acceptance criteria to ensure that batches of drug products meet each appropriate..
http://www.fda.gov/cder/guidance/4168dft.pdf (score=35)
Format and Content for the CMC Section of an Annual Report
...Regulatory specifications and analytical methods for the drug substance and drug..product should be listed.....during the reporting period, including immediate container labels, carton..labeling, and.....container and closure system to the original system in accordance..with compendial..
http://www.fda.gov/cder/guidance/cmc1.pdf (score=31)
Document
...using both public and private funds, their drug or biologic. FDA has, to date, Drug.....recommendation for a formulation.. be extended to May 22, 2002. SUMMARY: The IRS is.....wrapper is also the only container or .. Todd A. Stevenson, other designation that relates..
http://www.fda.gov/OHRMS/DOCKETS/98fr/042402a.pdf (score=29)
Packaging
...If a medicine dropper is incorporated as an integral part of the drug container or closure.....The identity of the source and a description of the formulation(s), process(es), and.....If there is a need for interchangeability of container/closure materials for the drug product from one composition or supplier..
http://www.fda.gov/cder/guidance/package.htm (score=94)
...A device that serves as a container for a drug or a device that is a drug delivery system attached to the drug container where the.....A liquid, powder, or other similar formulation intended only to serve as a component, part.....Required if a drug or the chemical form of the drug has not been legally marketed in the United States as a human drug for..
http://www.fda.gov/oc/ombudsman/drug-dev.htm (score=87)
Annex A Code of Federal Regulations (CFR)
...The segment that identifies the drug formulation is known as the Product Code and the segment.....First, the symbol appears prominently on the immediate container and on any outside container or wrapper and in a.....The term also includes repackaging or otherwise changing the container, wrapper, or labeling of any drug package to further the..
http://www.fda.gov/cder/drls/annexa.htm (score=86)
...14927 15-Jun-00 EAGLE STAINLESS CONTAINER "EAGLE STAINLESS CONTAINER AS MFG IN WARMINSTER.....14821 07-Apr-00 SKC INC SKYROL PET FILMS FOR PACKAGING DRUG PRODUCTS AS MFG IN COVINGTON.....FORMULATION 4588/40 GRAY TO FORMULATION 1888 GRAY AS MANUFACTURED IN LIONVILLE PA 14120 07..
http://www.fda.gov/cder/dmf/text/2Q2005ACTIVETYPE3TEXT.txt (score=86)
/a/content.2223
...Because bupropion is extensively metabolized, there is the potential for drug-drug interactions.....involving the sustained-release formulation of bupropion resulted from the different.....This supplement provides for revisions to the immediate container labeling for the 100 mg..
http://www.fda.gov/cder/ogd/rld/20358s16.pdf (score=34)
...20 Ingress or leaching of such chemicals into 21 drug product formulation poses a safety concern for 22.....area, fills 2 the container, and it withdraws, and then the 3 container is sealed and.....1 DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH DRUG..
http://www.fda.gov/ohrms/dockets/ac/04/transcripts/2004-4040T1.DOC (score=33)
stability guidance -draft
...Historically, all changes in drug product formulation were grouped together and required.....Additionally, compatibility of the preservative system with the container, closure.....between the drug and the container and closure and the potential introduction of..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=32)
Guidance for Industry
...Direct inoculation into the drug formulation provides an assessment of the effect of drug.....also require appropriate retesting of any component, drug product container, or closure that is subject.....product cannot be filter sterilyzed, and, therefore, each component in the formulation..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1874dft.pdf (score=31)
Variations in Drug Products that May be included in a Single A
...In this case,the studies are not related to a difference in formulation but have been.....Except for pharmacy bulk packages, products utilizing different container sizes.....Prior to October 1, 1990, applicants were to submit separate ANDAs for each drug dosage..
http://www.fda.gov/cder/guidance/2090fnl.pdf (score=31)
þÿ
...formulation components or leaching from the container closure system, chemical impurities.....drug products can and has occurred as a result of entry through LDPE container closure.....adequate acceptance criteria to ensure that batches of drug products meet each appropriate..
http://www.fda.gov/cder/guidance/4168dft.PDF (score=31)
Guidance for Industry
...Direct inoculation into the drug formulation provides an assessment of the effect of drug.....also require appropriate retesting of any component, drug product container, or closure that is subject.....product cannot be filter sterilyzed, and, therefore, each component in the formulation..
http://www.fda.gov/cder/guidance/1874dft.pdf (score=31)
Sterile Drug Products Produced by Aseptic Processing
...In an aseptic process, the drug product, container, and closure are first subjected to sterilization.....The sterile drug product and its container-closures should be protected by equipment of.....formulation processing stage. The total time for product filtration should be limited to..
http://www.fda.gov/cder/guidance/5882fnl.htm (score=30)
Guideline for Submitting Supporting Documentation
...Approval of reprocessing procedures must be obtained before release of the reprocessed drug or.....An amendment should be filed for any significant changes in formulation not proposed in.....Information relating to the container, closure, stability, and labeling are discussed in..
http://www.fda.gov/cder/guidance/drugprod.htm (score=30)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
